4//SEC Filing
HENDERSON MICHAEL THOMAS 4
Accession 0001104659-25-120758
CIK 0001974640other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 8:00 PM ET
Size
9.0 KB
Accession
0001104659-25-120758
Insider Transaction Report
Form 4
HENDERSON MICHAEL THOMAS
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-12-10$74.88/sh−9,435$706,493→ 1,223,552 total - Sale
Common Stock
2025-12-10$75.79/sh−10,005$758,279→ 1,213,547 total - Sale
Common Stock
2025-12-10$76.58/sh−560$42,885→ 1,212,987 total
Footnotes (3)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
- [F2]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.30 to $75.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.30 to $76.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Apogee Therapeutics, Inc.
CIK 0001974640
Entity typeother
Related Parties
1- filerCIK 0001779990
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 8:00 PM ET
- Size
- 9.0 KB